A New Blood Test to Differentiate Prostate Cancer from BPH Using GASP-1 Protein

In this video, I break down our latest research on a new blood test for distinguishing benign prostatic hyperplasia (BPH) from prostate cancer using GASP-1 protein levels. Collaborating with Halcyon Diagnostics and Dr. Rick Siderits from Rutgers University, we leveraged advanced tissue analysis, including dearraying TMAs, color separation, and intensity measurements using Python tools.

Our study reveals significant differences in GASP-1 expression between prostate cancer, BPH, and healthy tissues, highlighting its potential as a diagnostic marker. Watch to see how this breakthrough could complement PSA testing, reduce unnecessary biopsies, and improve prostate cancer detection.

For more details, find the full study in the October 2024 issue of CANCERS: https://www.mdpi.com/2072-6694/16/21/...

GitHub Link: https://github.com/bnsreenu/TMA-dearr...

Halcyon information: https://www.halcyonrx.com/


Video: 345